ASRM Statement on FACE Act Repeal Bill
June 10, 2025
For immediate release
Washington, DC—Today, the House Judiciary Committee marked up the attempted repeal of the FACE Act, H.R. 589, as introduced by U.S. Representative Chip Roy in January. In response, ASRM's Chief Advocacy and Policy Officer Sean Tipton issued the following statement:
"Less than one month ago, we saw an act of terrorism take place against a fertility clinic for the first time. The bombing in Palm Springs should be a signal to lawmakers that now is the time to strengthen protections provided through the FACE Act, which has served as a critical safeguard against extremist intimidation and abuse for decades. Proposing the repeal of the FACE Act in the immediate aftermath of a domestic attack on a medical facility is not only tone-deaf; it is dangerously irresponsible.
Prior to the mark-up, ASRM submitted a letter to committee leadership expressing opposition to this bill.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
ASRM Launches “Fighting for Our Future” Campaign to Rescue Reproductive Research
ASRM’s new campaign protects fertility research from federal cuts, preserving innovation, supporting scientists, and safeguarding reproductive health progress.
ASRM Statement on FACE Act Repeal Bill
ASRM opposes the repeal of the FACE Act, citing rising violence like the Palm Springs clinic bombing and urging Congress to uphold vital patient and provider protections.
Fertility & Sterility Publishes New Study Validating IVF Data Accuracy of a National Commercial Claims Database, Comparable with National IVF Registries
New study validates IVF data from commercial claims database, supporting its use by policymakers, employers, and researchers in expanding IVF coverage.
ASRM & RESOLVE Co-Host Federal Advocacy Day for Lawmakers to Hear from Providers, Patients, and Members of Family-Building and Fertility Community
ASRM and RESOLVE lead Advocacy Day, uniting all 50 states to push for IVF access, insurance mandates, and equitable fertility care for all.The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Topic Resources
ASRM Statement on FACE Act Repeal Bill
ASRM opposes the repeal of the FACE Act, citing rising violence like the Palm Springs clinic bombing and urging Congress to uphold vital patient and provider protections. View the Press Release
Assisted Reproductive Technology (ART) Oversight: Lessons for the United States from Abroad
A comprehensive analysis of global Assisted Reproductive Technology (ART) regulations, comparing policies, accessibility, and ethical considerations in various countries. View the advocacy resource
ASRM Releases Statement on IVF Policy Priorities
ASRM advocates for expanded IVF access, urging policy solutions that prioritize patient care, inclusivity, and medical decision-making free from political interference. View the Press Release
Just the Facts: IVF Policy Priorities
ASRM advocates for expanded IVF access, urging policy solutions that prioritize patient care, inclusivity, and medical decision-making free from political interference. View the advocacy resource
American Society for Reproductive Medicine Releases Fact Sheet on Biological Sex Differentiation
ASRM releases a new “Just the Facts” paper on biological sex, emphasizing scientific complexity and advocating for informed policymaking in reproductive medicine.
Just the Facts: Biological Sex
Biological sex is a complex, multidimensional construct influenced by anatomy, genetics, and hormones. Efforts to oversimplify it ignore scientific reality. View the advocacy resource
ASRM Town Hall - What to Expect from 2025 Legislative Sessions
Updates on the 2024 election outcomes, their policy impact on reproductive healthcare, and evolving state legislation affecting IVF, abortion, and more. View the ASRM Town Hall Video
Family members as gamete donors or gestational carriers: an Ethics Committee opinion (2024)
The use of adult intrafamilial gamete donors and gestational surrogates is ethically acceptable when all participants are fully informed and counseled. View the Committee Document
Financial ‘‘risk-sharing’’ or refund programs in assisted reproduction: an Ethics Committee opinion (2023)
Financial ‘‘risk-sharing’’ fee structures in programs charge patients a higher initial fee but provide reduced fees for subsequent cycles. View the Committee Document
Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion (2023)
Planned oocyte cryopreservation is an ethically permissible procedure that may help individuals avoid future infertility. View the Committee Opinion
Ethical considerations for telemedical delivery of fertility care: an Ethics Committee opinion (2024)
Telemedicine has the potential to increase access to and decrease the cost of care. View the Committee Opinion
Provision of fertility services for women at increased risk of complications during fertility treatment or pregnancy: an Ethics Committee opinion (2022)
Providers may conclude that the medical risks of fertility treatment for a given patient are too high, in which case it is ethical to decline to provide treatment. View the Committee Opinion
Access to fertility services by transgender and nonbinary persons: an Ethics Committee opinion (2021)
The provision of fertility services to transgender individuals and the denial of access to fertility services is not justified. View the Committee Opinion
Ethics in embryo research: a position statement by the ASRM Ethics in Embryo Research Task Force and the ASRM Ethics Committee (2020)
Scientific research using human embryos advances human health and offspring well-being and provides vital insights into the mechanisms for reproduction. View the Committee Opinion
Interpretation of clinical trial results: a committee opinion (2020)
Evidence from clinical trials is fundamental to ethical medical practice. View the Committee Opinion
Compassionate transfer: patient requests for embryo transfer for nonreproductive purposes (2020)
A patient request to transfer embryos into her body in a location or at a time when pregnancy is highly unlikely ... View the Committee Opinion
Interests, obligations, and rights in gamete and embryo donation: an Ethics Committee opinion (2019)
This Ethics Committee report outlines the interests, obligations, and rights of all parties involved in gamete and embryo donation. View the Committee Opinion
